Briefings on Accreditation and Quality In what is likely a result of a new survey matrix, new or revised Life Safety and Environment of Care requirements, and increased pressure from CMS, hospitals scored much worse across the board on The Joint Commission’s list of most challenging standards for the first half of 2017, compared to the same period last year. 
Marketing Spotlight Presented on: 1:00-2:30 p.m. Eastern, Monday, October 30, 2017
Presented by: Patricia C. Kienle, RPh, MPA, FASHP
Level of Program: Intermediate
Who should listen: Accreditation specialists, regulatory officers, safety officers, pharmacists, and any healthcare staff who work with hazardous drugs
Registration: https://hcmarketplace.com/usp-800-drug-compliance-safety-2018 Making drugs is risky business, even when it’s done in hospital pharmacies. From the person carrying the chemicals from the loading bay to the person doing the actual mixing, improper exposure to hazardous medication compounding substances can have lasting and devastating health effects. On December 1, 2019, the U.S. Pharmacopeial Convention’s (USP) Chapter <800> will become fully enforceable by regulators. This chapter addresses the physical environment and equipment needed to maintain sterility and protect the 8 million healthcare workers potentially exposed to hazardous vapors and particles each year. USP is expected to be adopted by many regulators and accreditors, such as state pharmacy boards and The Joint Commission.
Join expert speaker Patricia C. Kienle, RPh, MPA, FASHP, for this 90-minute webinar, as she dives into the different types of hazardous drugs and the requirements for compliance. Kienle will also teach participants how to perform an Assessment of Risk and how to stay safe when handling hazardous drugs. Registration is still open, sign up today!
Editor's Picks October 17, 2017
Is All of Your Team In The Know? Our weekly e-newsletters can keep your team abreast of up-to-date industry information; including expert analysis where you need it most. Subscribe to any -- or all -- of our e-newsletters. |
